0%

est. 2Y upside i

HealthcareSeries A

We are a frontier AI lab building generative models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering.

Rank

#2837

Sector

Biotechnology

Est. Liquidity

~5Y

Data Quality

Data: Low

Quantitative upside analysis is impossible due to missing revenue, growth, and valuation data.

Last updated: July 3, 2026

Bull (20%)0%

Insufficient data to quantify. Potential for high growth if platform gains traction with partnerships, but valuation unknown.

Base (55%)0%

Cannot compute due to missing revenue and valuation. Typical early-stage biotech upside requires years of development.

Bear (25%)-100%

High risk of failure given early stage, high burn, and strong incumbent threats. Preference stack would wipe out common equity.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Funding Intensity

0%

Total funding of $50M is likely a large fraction of an unknown valuation, implying severe preference overhang for common stock.

Dilution Risk

high

Early stage with no revenue suggests multiple future rounds before exit, diluting common equity significantly.

Secondary Liquidity

none

No secondary market data available; early-stage private company likely offers no liquidity.

AI Integration — 6 roles

Biology — 1 role

Operations — 1 role

View all 14 open roles at Latent Labs →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Latent Labs's data — designed to show you've done your homework.

  • 1

    “What is the current valuation and how was it determined?”

  • 2

    “What is the revenue run rate and growth trajectory?”

  • 3

    “What is the expected timeline and path to liquidity (IPO or acquisition)?”

Community

Valuation Sentiment

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.